Want to join the conversation?
$NTAP 1Q16 Call: Deferred revenue decreased by $131MM in 1Q16 vs. 4Q15 and decreased $10MM from 1Q15. 1Q16, cash from operations was approx. $129MM vs. $216MM in 1Q15. At 7% of revenue, free cash flow was down as expected due to lower net income resulting from the YoverY revenue decline.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?